Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 10, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000094.pdf 0001883850-22-000094.xls
Nov 08, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000092.pdf 0001883850-22-000092.xls
Nov 07, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000090.pdf 0001883850-22-000090.xls
Nov 07, 2022	UPLOAD	UPLOAD	View HTML 0000000000-22-012109.pdf
Nov 03, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-22-000029.pdf 0001804220-22-000029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 03, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-22-000031.pdf 0001804220-22-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 03, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000088.pdf 0001883850-22-000088.xls
Nov 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000085.pdf 0001883850-22-000085.xls
Nov 02, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000086.pdf 0001883850-22-000086.xls
Oct 18, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000082.pdf 0001883850-22-000082.xls

Data provided by Kaleidoscope.

Investors & Media